anthera logo

Corporate Profile

Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation and autoimmune diseases.

Recent Releases

Jul 28, 2014
Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update

Jul 14, 2014
Anthera Pharmaceuticals Announces Acquisition of Sollpura® (liprotamase) for Exocrine Pancreatic Insufficiency From Eli Lilly and Company

View all releases »

Stock Chart
Stock price graph
Stock Quote
Anthera Pharmaceuticals
Price: 2.57
Change: - 0.03
Day High: 2.59
Day Low: 2.56
Volume: 22,200
Delayed at least 20 minutes.
Provided by eSignal.
Back to Top

© 2014 Anthera Pharmaceuticals, Inc., All Rights Reserved.